PL3797772T3 - Rebamipid do zastosowania w zapobieganiu i leczeniu choroby Leśniowskiego-Crohna - Google Patents
Rebamipid do zastosowania w zapobieganiu i leczeniu choroby Leśniowskiego-CrohnaInfo
- Publication number
- PL3797772T3 PL3797772T3 PL19020504.7T PL19020504T PL3797772T3 PL 3797772 T3 PL3797772 T3 PL 3797772T3 PL 19020504 T PL19020504 T PL 19020504T PL 3797772 T3 PL3797772 T3 PL 3797772T3
- Authority
- PL
- Poland
- Prior art keywords
- rebamipide
- crohn
- disease
- prevention
- treatment
- Prior art date
Links
- 208000011231 Crohn disease Diseases 0.000 title 1
- ALLWOAVDORUJLA-UHFFFAOYSA-N Rebamipida Chemical compound C=1C(=O)NC2=CC=CC=C2C=1CC(C(=O)O)NC(=O)C1=CC=C(Cl)C=C1 ALLWOAVDORUJLA-UHFFFAOYSA-N 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229950004535 rebamipide Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19020504.7A EP3797772B1 (en) | 2019-09-03 | 2019-09-03 | Rebamipide for use in prevention and treatment of crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3797772T3 true PL3797772T3 (pl) | 2024-05-06 |
Family
ID=67874203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19020504.7T PL3797772T3 (pl) | 2019-09-03 | 2019-09-03 | Rebamipid do zastosowania w zapobieganiu i leczeniu choroby Leśniowskiego-Crohna |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220304998A1 (pl) |
| EP (1) | EP3797772B1 (pl) |
| JP (1) | JP7629448B2 (pl) |
| KR (1) | KR20220062549A (pl) |
| CN (1) | CN114340628A (pl) |
| BR (1) | BR112022003918A2 (pl) |
| CA (1) | CA3152950A1 (pl) |
| ES (1) | ES2968628T3 (pl) |
| MX (1) | MX2022002629A (pl) |
| PL (1) | PL3797772T3 (pl) |
| WO (1) | WO2021043846A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115671107B (zh) * | 2022-12-29 | 2023-04-04 | 文韬创新药物研究（北京）有限责任公司 | 用于解酒的复方药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4370451B2 (ja) | 2001-09-28 | 2009-11-25 | 大塚製薬株式会社 | 医薬組成物 |
| US7417037B2 (en) | 2004-01-20 | 2008-08-26 | The Board Of Regents Of The University Of Oklahoma | Compositions and methods of treatment for inflammatory diseases |
| JP2006096702A (ja) | 2004-09-29 | 2006-04-13 | Omikai | 腸薬 |
| KR101436728B1 (ko) * | 2012-03-20 | 2014-09-02 | 가톨릭대학교 산학협력단 | 골수유래억제세포 및 레바미피드를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
| JP6653120B2 (ja) | 2014-10-31 | 2020-02-26 | 千寿製薬株式会社 | Ｉｋａｒｏｓ阻害に基づく抗炎症薬 |
-
2019
- 2019-09-03 EP EP19020504.7A patent/EP3797772B1/en active Active
- 2019-09-03 ES ES19020504T patent/ES2968628T3/es active Active
- 2019-09-03 PL PL19020504.7T patent/PL3797772T3/pl unknown
-
2020
- 2020-09-02 BR BR112022003918A patent/BR112022003918A2/pt not_active Application Discontinuation
- 2020-09-02 WO PCT/EP2020/074501 patent/WO2021043846A1/en not_active Ceased
- 2020-09-02 MX MX2022002629A patent/MX2022002629A/es unknown
- 2020-09-02 CN CN202080061729.3A patent/CN114340628A/zh active Pending
- 2020-09-02 CA CA3152950A patent/CA3152950A1/en active Pending
- 2020-09-02 US US17/638,871 patent/US20220304998A1/en active Pending
- 2020-09-02 KR KR1020227010811A patent/KR20220062549A/ko not_active Ceased
- 2020-09-02 JP JP2022513870A patent/JP7629448B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114340628A (zh) | 2022-04-12 |
| EP3797772A1 (en) | 2021-03-31 |
| WO2021043846A1 (en) | 2021-03-11 |
| JP7629448B2 (ja) | 2025-02-13 |
| CA3152950A1 (en) | 2021-03-11 |
| MX2022002629A (es) | 2022-06-02 |
| JP2022546118A (ja) | 2022-11-02 |
| US20220304998A1 (en) | 2022-09-29 |
| BR112022003918A2 (pt) | 2022-05-31 |
| ES2968628T3 (es) | 2024-05-13 |
| EP3797772B1 (en) | 2023-10-18 |
| KR20220062549A (ko) | 2022-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268327A (en) | A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases | |
| IL323583A (en) | Methods for treating and preventing Alzheimer's disease | |
| IL280475B1 (en) | Pharmaceutical preparation for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease | |
| SG11202011296VA (en) | Compositions and methods for the treatment of parkinson's disease | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| IL282904A (en) | Therapeutic microbiota for the treatment and/or prevention of dysbiosis | |
| IL289758B1 (en) | Proportin inhibitors for use in the prevention and treatment of kidney injury | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| PT4031117T (pt) | Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos | |
| ZA202101489B (en) | Compositions and methods for the treatment of parkinson's disease | |
| IL290726A (en) | Use of Brazicomb to treat Crohn's disease | |
| PL3797772T3 (pl) | Rebamipid do zastosowania w zapobieganiu i leczeniu choroby Leśniowskiego-Crohna | |
| IL286818A (en) | Mirikizumab for use in a method of treating crohns disease | |
| PL3937948T3 (pl) | Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu chorób nerwowo-mięśniowych | |
| PL3797771T3 (pl) | Rebamipid do stosowania w zapobieganiu i leczeniu celiakii | |
| SG10201907677QA (en) | Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases. | |
| IL268131A (en) | A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of alzheimer's disease | |
| ZA201806864B (en) | Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients | |
| PT3595660T (pt) | Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólica | |
| GB2610895C (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL284298A (en) | Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases | |
| EP4058043A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN’S DISEASE | |
| GB202107297D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL279221A (en) | Use of halogen compounds for the treatment and prevention of tissue damage and syndrome after intensive care |